University of Basel, Basel, Switzerland.
Clarunis, Department of Visceral Surgery, University Centre for Gastrointestinal and Liver Diseases, St. Claraspital and University Hospital, Basel, Switzerland.
Obes Facts. 2020;13(6):584-595. doi: 10.1159/000511928. Epub 2020 Nov 17.
Most patients with severe obesity show glucose intolerance. Early after sleeve gastrectomy (LSG) or gastric bypass (LRYGB), a marked amelioration in glycemic control occurs. The underlying mechanism is not yet clear.
To determine whether the improvement in glycemic control on the level of endocrine pancreatic function is due to an increased first-phase insulin secretion comparing LRYGB to LSG.
University of Basel Hospital and St. Clara Research Ltd., Basel, Switzerland.
Sixteen morbidly obese patients with severe obesity and different degrees of insulin resistance were randomized to LSG or LRYGB, and islet cell functions were tested by intravenous glucose and intravenous arginine administration before and 4 weeks after surgery.
Fasting insulin and glucose levels and homeostasis model assessment insulin resistance were significantly lower in both groups after surgery compared to baseline, while no change was seen in fasting C-peptide, amylin, and glucagon. After intravenous glucose stimulation, no statistically significant pre- to postoperative change in area under the curve (AUC 0-60 min) was seen for insulin, glucagon, amylin, and C-peptide. No statistically significant pre- to postoperative change in incremental AUC for first-phase insulin release (AUC 0-10 min), second-phase insulin secretion (AUC 10-60 min), and insulin/glucose ratio could be shown in either group. Arginine-stimulated insulin and glucagon release showed no pre- to postoperative change.
Intravenous glucose and arginine administrations show no pre- to postoperative changes of insulin release, amylin, glucagon, or C-peptide concentrations, and no differences between LRYGB and LSG were found. The postoperative improvement in glycemic control is not caused by changes in endocrine pancreatic hormone secretion.
大多数重度肥胖患者表现为葡萄糖耐量受损。袖状胃切除术(LSG)或胃旁路术(LRYGB)后早期,血糖控制明显改善。其潜在机制尚不清楚。
确定血糖控制的改善是否归因于 LRYGB 相较于 LSG 时第一时相胰岛素分泌的增加。
巴塞尔大学医院和巴塞尔圣克拉拉研究有限公司,瑞士。
16 例患有严重肥胖症和不同程度胰岛素抵抗的病态肥胖患者被随机分为 LSG 或 LRYGB 组,在手术前和手术后 4 周通过静脉葡萄糖和静脉精氨酸输注来测试胰岛细胞功能。
与基线相比,两组手术后空腹胰岛素和血糖水平以及稳态模型评估胰岛素抵抗均显著降低,而空腹 C 肽、胰淀素和胰高血糖素无变化。静脉葡萄糖刺激后,胰岛素、胰高血糖素、胰淀素和 C 肽的曲线下面积(0-60 分钟 AUC)无统计学意义的术前到术后变化。两组中第一时相胰岛素释放(0-10 分钟 AUC)、第二时相胰岛素分泌(10-60 分钟 AUC)和胰岛素/血糖比值的增量 AUC 均无统计学意义的术前到术后变化。精氨酸刺激的胰岛素和胰高血糖素释放无术前到术后变化。
静脉葡萄糖和精氨酸给药显示胰岛素、胰淀素、胰高血糖素或 C 肽浓度无术前到术后变化,并且在 LRYGB 和 LSG 之间未发现差异。术后血糖控制的改善不是由于内分泌胰腺激素分泌的变化引起的。